BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 30, 2015
View Archived Issues
Volanesorsen named U.S. orphan drug for familial chylomicronemia syndrome
Read More
FluBlok Quadrivalent more effective than traditional influenza vaccine
Read More
Conatus reports baseline data from first patients in phase IIb trial of emricasan
Read More
Immunovaccine and Incyte collaborate to investigate combination of DPX-Survivac and epacadostat
Read More
Invenra and Oxford BioTherapeutics collaborate to discover therapeutic antibodies targeting cancer
Read More
Phase Ib results for BioChaperone Lispro in type 1 diabetes
Read More
SB-204 8% is well-tolerated in subjects with acne vulgaris
Read More
Model of cetuximab resistance in CRC allows testing of other treatments
Read More
Patrys awards Chinese license for cancer therapy PAT-SC1
Read More
Oral suspension formulation of Orfadin receives European approval
Read More
Bioiberica to start trials for PRJ-212 for Alzheimer's disease
Read More
European orphan drug designation for Cabaletta in spinocerebellar ataxia
Read More
Galectin Therapeutics initiates phase II study of GR-MD-02 in NASH
Read More
Sarepta Therapeutics completes NDA submission to FDA for eteplirsen
Read More
RedHill initiates phase I/II study of ABC-294640 in refractory DLBCL
Read More
rF-GM-CSF and rF-TRICOM are safe is patients with bladder carcinoma
Read More
Bristol-Myers Squibb develops HCV NS5A inhibitors
Read More
Glenmark Pharmaceuticals patents RORgamma-t modulators
Read More
Daiichi Sankyo discloses LCAT activators
Read More
Merck & Co. reports sGC activators
Read More
Shanghai Hansoh Biomedical presents ALK inhibitors
Read More
Incyte presents data on INCB-040093
Read More
FDA accepts IND for phase I trial of JCAR-017 for relapsed/refractory B-cell NHL
Read More
SrtarD6 gene polymorphism in Alzheimer's disease
Read More
Intercept files for approval of obeticholic acid for primary biliary cirrhosis in U.S. and E.U.
Read More
Bayer files for Japanese approval of BAY-81-8973 for hemophilia A
Read More
Novartis to acquire Spinifex Pharmaceuticals
Read More